| Title |
Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine
|
|---|---|
| Published in |
Cancer Chemotherapy and Pharmacology, October 2006
|
| DOI | 10.1007/s00280-006-0355-x |
| Pubmed ID | |
| Authors |
Timothy H. Marczylo, Richard D. Verschoyle, Darren N. Cooke, Paolo Morazzoni, William P. Steward, Andreas J. Gescher |
| Abstract |
Curcumin, a major constituent of the spice turmeric, suppresses expression of the enzyme cyclooxygenase 2 (Cox-2) and has cancer chemopreventive properties in rodents. It possesses poor systemic availability. We explored whether formulation with phosphatidylcholine increases the oral bioavailability or affects the metabolite profile of curcumin. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 250 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | <1% |
| Italy | 2 | <1% |
| India | 1 | <1% |
| Brazil | 1 | <1% |
| Unknown | 244 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 39 | 16% |
| Student > Master | 38 | 15% |
| Student > Bachelor | 33 | 13% |
| Student > Ph. D. Student | 29 | 12% |
| Other | 15 | 6% |
| Other | 39 | 16% |
| Unknown | 57 | 23% |
| Readers by discipline | Count | As % |
|---|---|---|
| Agricultural and Biological Sciences | 41 | 16% |
| Pharmacology, Toxicology and Pharmaceutical Science | 38 | 15% |
| Medicine and Dentistry | 31 | 12% |
| Chemistry | 27 | 11% |
| Biochemistry, Genetics and Molecular Biology | 18 | 7% |
| Other | 29 | 12% |
| Unknown | 66 | 26% |
Attention Score in Context
This research output has an Altmetric Attention Score of 34. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 May 2022.
All research outputs
#1,069,046
of 23,815,455 outputs
Outputs from Cancer Chemotherapy and Pharmacology
#20
of 2,501 outputs
Outputs of similar age
#1,688
of 68,265 outputs
Outputs of similar age from Cancer Chemotherapy and Pharmacology
#1
of 18 outputs
Altmetric has tracked 23,815,455 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,501 research outputs from this source. They receive a mean Attention Score of 4.1. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 68,265 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 18 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.